The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

Is it red or itchy? Are you having trouble breathing ... “If there are nasal symptoms associated with facial pressure, especially with swelling around the eyelids and in the forehead between the eyes, ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Do you often find yourself constantly scratching your skin because it feels dry and uncomfortable? Dry, itchy skin is a ...

Lilly has exclusive rights for development and commercialization of EBGLYSS in the U.S. and the rest of the world outside Europe. Lilly's partner Almirall S.A. has licensed the rights to develop and ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNP Current treatment options leave many patients with uncontrolled disease and ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...

The most common side effects of ADBRY include: upper respiratory tract infections Eye and eyelid inflammation, including redness, swelling, and itching Injection site reactions High count of a certain ...

PsA is a chronic, inflammatory disease in and around the joints as well as the surrounding tendons and ligaments. It is ...

32.Of course, you know that hair turns gray and white as you get older. But sometimes, this happens rather rapidly — this guy ...

An allergic reaction happens when your body attacks a foreign, and typically harmless, substance. Here’s how to tell if ...